Welcome Back
Join CoinTime
Sign in with email
Sign up with email
Check your inbox
Sight Diagnostics
About
Blood diagnostics company that uses machine vision and AI to transform health systems and outcomes through fast and accurate blood testing.
- Tel Aviv,Tel Aviv,Israel
- 101 - 250
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $6M
- Industries
- Artificial Intelligence,Computer Vision,Health Care,Health Diagnostics,Machine Learning,Medical,Medical Device
- Founded date
- Jan 1, 2011
- Number Of Employee
- 101 - 250
- Operating Status
- Active
- Legal Name
- Sight Diagnostics Inc.
Sight Diagnostics is a blood diagnostic company that combines machine vision and AI to improve health through fast, convenient and accurate diagnostics. Developed over almost a decade of research, Sight’s technology combines the latest innovations in blood sample preparation, optics, chemistry, biology, physics and computer science.
Sight’s first product, Parasight*, has diagnosed malaria in close to 1 million tests across 24 countries. Sight OLO, Sight’s latest FDA 510(k) cleared blood analyzer, digitizes blood with only 2 drops of a finger prick or venous sample and provides lab-grade Complete Blood Count results in minutes. Sight has growing offices in the UK, the US and Israel, and commercial footprint on 5 continents.
*Note: Parasight is not available for sale in the US and did not receive FDA clearance for use in the US.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 5, 2020 | Series D | $71M | 6 |
Koch Disruptive Technologies
|
— | Detail |
| Feb 14, 2019 | Series C | $27.80M | 6 |
Longliv Ventures
|
— | Detail |
| Sep 1, 2016 | Series B | $16M | 3 | — | — | Detail |
| Nov 1, 2014 | Series A | $6M | 4 | — | — | Detail |
| Aug 1, 2011 | Seed | $3M | 2 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Koch Disruptive Technologies
|
Yes | Series D |
OurCrowd
|
— | Series D |
Clal Biotechnology Industries
|
— | Series D |
GO CAPITAL
|
— | Series D |
|
Longliv Ventures
|
— | Series D |
New Alliance Capital
|
— | Series D |
|
|
— | Series C |
|
|
— | Series C |
GEOC
|
— | Series B |
Emery Capital
|
— | Series A |
Employee Profiles
